JAGX vs. CRVS, HOOK, CNTB, LFVN, TPST, AFMD, LPTX, MRNS, RVPH, and ANEB
Should you be buying Jaguar Health stock or one of its competitors? The main competitors of Jaguar Health include Corvus Pharmaceuticals (CRVS), Hookipa Pharma (HOOK), Connect Biopharma (CNTB), LifeVantage (LFVN), Tempest Therapeutics (TPST), Affimed (AFMD), Leap Therapeutics (LPTX), Marinus Pharmaceuticals (MRNS), Reviva Pharmaceuticals (RVPH), and Anebulo Pharmaceuticals (ANEB). These companies are all part of the "pharmaceutical preparations" industry.
Jaguar Health (NASDAQ:JAGX) and Corvus Pharmaceuticals (NASDAQ:CRVS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, community ranking, profitability, media sentiment, risk and valuation.
Jaguar Health received 1549 more outperform votes than Corvus Pharmaceuticals when rated by MarketBeat users. Likewise, 89.12% of users gave Jaguar Health an outperform vote while only 62.31% of users gave Corvus Pharmaceuticals an outperform vote.
Jaguar Health has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500. Comparatively, Corvus Pharmaceuticals has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500.
12.0% of Jaguar Health shares are held by institutional investors. Comparatively, 46.6% of Corvus Pharmaceuticals shares are held by institutional investors. 0.0% of Jaguar Health shares are held by company insiders. Comparatively, 31.3% of Corvus Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Corvus Pharmaceuticals has lower revenue, but higher earnings than Jaguar Health.
Corvus Pharmaceuticals has a consensus price target of $6.88, indicating a potential upside of 250.77%. Given Corvus Pharmaceuticals' higher possible upside, analysts plainly believe Corvus Pharmaceuticals is more favorable than Jaguar Health.
Corvus Pharmaceuticals has a net margin of 0.00% compared to Jaguar Health's net margin of -423.11%. Corvus Pharmaceuticals' return on equity of -59.63% beat Jaguar Health's return on equity.
In the previous week, Corvus Pharmaceuticals had 15 more articles in the media than Jaguar Health. MarketBeat recorded 18 mentions for Corvus Pharmaceuticals and 3 mentions for Jaguar Health. Corvus Pharmaceuticals' average media sentiment score of 0.61 beat Jaguar Health's score of 0.49 indicating that Corvus Pharmaceuticals is being referred to more favorably in the news media.
Summary
Corvus Pharmaceuticals beats Jaguar Health on 11 of the 14 factors compared between the two stocks.
Get Jaguar Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding JAGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Jaguar Health Competitors List
Related Companies and Tools
